• Novartis
• AbbVie
• InflaRx
• Janssen Biotech
• Beijing Defengrei Biotechnology
• Ambulero
• Visterra
• ChemoCentryx
• GlaxoSmithKline
• Roche
• CytoDyn
• Toleranzia
• Citryll
• Levolta
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2022 | 60 | DelveInsight | ASDR-599256 |
• Novartis
• AbbVie
• InflaRx
• Janssen Biotech
• Beijing Defengrei Biotechnology
• Ambulero
• Visterra
• ChemoCentryx
• GlaxoSmithKline
• Roche
• CytoDyn
• Toleranzia
• Citryll
• Levolta